Movatterモバイル変換


[0]ホーム

URL:


AU2001240001A1 - Oral dosage form for administration of the combination of tegafur, uracil, folinic acid, and oxaliplatin and method of using the same - Google Patents

Oral dosage form for administration of the combination of tegafur, uracil, folinic acid, and oxaliplatin and method of using the same

Info

Publication number
AU2001240001A1
AU2001240001A1AU2001240001AAU4000101AAU2001240001A1AU 2001240001 A1AU2001240001 A1AU 2001240001A1AU 2001240001 AAU2001240001 AAU 2001240001AAU 4000101 AAU4000101 AAU 4000101AAU 2001240001 A1AU2001240001 A1AU 2001240001A1
Authority
AU
Australia
Prior art keywords
tegafur
oxaliplatin
uracil
administration
combination
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001240001A
Inventor
Michel Chazard
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bristol Myers Squibb Co
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb CofiledCriticalBristol Myers Squibb Co
Publication of AU2001240001A1publicationCriticalpatent/AU2001240001A1/en
Abandonedlegal-statusCriticalCurrent

Links

Classifications

Landscapes

AU2001240001A2000-03-082001-03-01Oral dosage form for administration of the combination of tegafur, uracil, folinic acid, and oxaliplatin and method of using the sameAbandonedAU2001240001A1 (en)

Applications Claiming Priority (5)

Application NumberPriority DateFiling DateTitle
US18784200P2000-03-082000-03-08
US601878422000-03-08
US23114700P2000-09-082000-09-08
US602311472000-09-08
PCT/US2001/006730WO2001066102A2 (en)2000-03-082001-03-01Oral dosage form for administration of the combination of tegafur, uracil, folinic acid, and oxaliplatin and method of using the same

Publications (1)

Publication NumberPublication Date
AU2001240001A1true AU2001240001A1 (en)2001-09-17

Family

ID=26883457

Family Applications (1)

Application NumberTitlePriority DateFiling Date
AU2001240001AAbandonedAU2001240001A1 (en)2000-03-082001-03-01Oral dosage form for administration of the combination of tegafur, uracil, folinic acid, and oxaliplatin and method of using the same

Country Status (5)

CountryLink
US (1)US6602870B2 (en)
AR (1)AR027624A1 (en)
AU (1)AU2001240001A1 (en)
PE (1)PE20020769A1 (en)
WO (1)WO2001066102A2 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
US6476068B1 (en)2001-12-062002-11-05Pharmacia Italia, S.P.A.Platinum derivative pharmaceutical formulations
FR2834641B1 (en)*2002-01-142005-04-22Ct Regional De Lutte Contre Le PROTECTION OF NEUROTOXICITY OF OXALIPLATIN BY ADMINISTRATION OF CALCIUM AND MAGNESIUM
EP1604991B1 (en)*2003-03-142008-09-17Taiho Pharmaceutical Co., Ltd.Antitumor effect potentiator and antitumor agent
KR100844477B1 (en)*2004-06-092008-07-07다이호야쿠힌고교 가부시키가이샤 Anti-tumor effect enhancers, anti-tumor agents and cancer treatment methods
US20080306073A1 (en)*2004-06-092008-12-11Katsuhisa KoizumiAntitumor Effect Potentiator, Antitumor Preparation, and Method for Treating Cancer
US20080081301A1 (en)*2006-10-032008-04-03Hannum Mark CLow NOx combustion
AU2008222592B2 (en)*2007-03-022013-09-26Detsamma Investments Pty LtdCompositions and methods for delivery of anti-cancer agents
US8007470B2 (en)*2007-07-102011-08-30Cook Medical Technologies LlcMinimally invasive medical device and method for delivery of therapeutic or diagnostic agents into a vessel wall
AU2008356312B2 (en)*2008-05-122015-04-09Shizuoka PrefectureAntitumor agent, kit, and method for treating cancer

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
US4328229A (en)1978-03-291982-05-04Taiho Pharmaceutical Company LimitedAnti-cancer composition for delivering 5-fluorouracil to cancer tissues
US5534513A (en)1991-09-051996-07-09Taiho Pharmaceutical Company, Ltd.Antitumor potentiator and antitumor composition

Also Published As

Publication numberPublication date
AR027624A1 (en)2003-04-02
US6602870B2 (en)2003-08-05
PE20020769A1 (en)2002-09-06
WO2001066102A2 (en)2001-09-13
WO2001066102A3 (en)2001-12-20
US20020045632A1 (en)2002-04-18

Similar Documents

PublicationPublication DateTitle
IL161431A0 (en)beta-PHENYL-alpha-OXYSUBSTITUTED PROPIONIC ACID DERIVATIVES, PROCESS FOR THE PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
HUP0202795A3 (en)Pyrimidine and pyrazine derivatives, pharmaceutical compositions containing them and their use
HUP0301722A3 (en)Pyrimidine derivatives, pharmaceutical compositions containing them and their use
HUP0401346A3 (en)Hiv inhibiting pyrimidines derivatives, process for their preparation and pharmaceutical compositions containing them
HUP0201122A3 (en)Pyrimidinone compounds, process for their preparation and pharmaceutical compositions containing them
PL396568A1 (en)Crystalline O-desmethyl-venlafaxine succinate, the pharmaceutical composition, pharmaceutical dosage form, oral dosage form, application and process for the preparation of crystalline O-desmethyl-venlafaxine succinate
HUP0105114A3 (en)Quinazolinone derivatives, pharmaceutical compositions containing them, their use and process for their preparation
SI1345910T1 (en)Quinazoline derivatives, medicaments containing said compounds, their utilization and method for the production thereof
HUP0401083A3 (en)4-amino-6-phenyl-pyrrolo [2,3-d] pyrimidine derivatives, pharmaceutical compositions containing them and process for the preparation of the compounds
AU2001284021A1 (en)Quinazoline derivatives, medicaments containing these compounds, their use, and methods for the production thereof
IL138969A0 (en)Anthranilic acid derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same
HK1052510A1 (en)Novel hydantoin, thiohydantoin, pyrimidinedione and thioxopyrimidinone derivatives, preparation method and use as medicines.
PL363967A1 (en)Method and dosage form for treating tumors by the administration of tegafur, uracil, folinic acid, paclitaxel and carboplatin
HUP0203385A3 (en)Pyrimidine derivatives, process for their preparation, pharmaceutical compositions containing them and their use
ZA200109602B (en)Purine derivatives, preparation method and pharmaceutical compositions containing same.
AU2001240001A1 (en)Oral dosage form for administration of the combination of tegafur, uracil, folinic acid, and oxaliplatin and method of using the same
AU2001234107A1 (en)Benzoic acid derivatives, process for producing the same and drugs containing the same as the active ingredient
EP1490358A4 (en)6-(4-substituted-anilino)pyrimidine derivatives, method for the preparation thereof and antiviral pharmaceutical composition comprising the same
HUP0303045A3 (en)Pyrimidine derivatives, process for their preparation, pharmaceutical compositions containing them and their use
HUP0202832A3 (en)New pyrimidine-2,4,6-trione derivatives, processes for their production and pharmaceutical agents containing these compounds
AU2001296746A1 (en)Oral dosage forms for administration of the combination of tegafur, uracil, folinic acid, and irinotecan and method of using the same
PL373247A1 (en)Method for treating tumors by the administration of tegafur, uracil, folinic acid, and cyclophosphamide
AU2002325614A1 (en)Compounds containing lactic acid elements, method for the production and use thereof as pharmaceutically active substances
AU2002213119A1 (en)Oral dosage forms for administration of the combination of tegafur, uracil, folinic acid, and vinorelbine and method of using the same
AU2001241067A1 (en)Omega-substituted phenyl-prostaglandin e-alcohols, process for producing the same and drugs containing the same as the active ingredient

[8]ページ先頭

©2009-2025 Movatter.jp